Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Helix Kapital acquires Holms Industri
Mandate

Helix Kapital acquires Holms Industri

July 06, 2018 M&A

Vinge has advised Helix Kapital in connection with the acquisition of Holms Industri.

Holms was founded in 1927 and develops, manufactures and sells tools for regular maintenance of walls and exterior areas. Holms has a turnover of approximately MSEK 100, the company’s head office is situated in Motala and the company has approximately 50 employees.

Vinge’s team consisted of Johan Winnerblad, Carl Sander, Fredric Reissmüller and Arvid Axelryd.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026